Skip to main content
. 2022 Jun 27;40(33):3808–3816. doi: 10.1200/JCO.21.02986

FIG 4.

FIG 4.

Neutralizing antibody response to Delta, Beta, and Omicron SARS-CoV-2 variants in patients with NSCLC after mRNA vaccination. Live virus neutralization of WT (614D), B.1.617.2 (Delta), B.1.351 (Beta), and B.1.1.529 (Omicron) virus by patients with NSCLC 30 days after two-dose primary mRNA vaccination. The figure shows the mean and SEM. ***P ≤ .001, ****P ≤ .0001. FRNT, Focus Reduction Neutralization Test; NSCLC, non–small-cell lung cancer; WT, wild type.